Last Updated: September 24, 2026

KETOPROFEN - Generic Drug Details

Name: KETOPROFEN Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for ketoprofen and what is the scope of freedom to operate?

Ketoprofen is the generic ingredient in six branded drugs marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Wyeth Pharms Inc, Misemer, Rising, Teva, Wyeth Ayerst, Novartis, Bayer, Perrigo, and Wyeth Cons, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Five suppliers are listed for this compound.

Summary for KETOPROFEN

US Patents:	0
Tradenames:	6
Applicants:	12
NDAs:	15
Finished Product Suppliers / Packagers:	5
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	109
Patent Applications:	6,699
Drug Prices:	Drug price trends for KETOPROFEN
Drug Sales Revenues:	Drug sales revenues for KETOPROFEN
What excipients (inactive ingredients) are in KETOPROFEN?	KETOPROFEN excipients list
DailyMed Link:	KETOPROFEN at DailyMed

See drug prices for KETOPROFEN

Drug Sales Revenue Trends for KETOPROFEN

See drug sales revenues for KETOPROFEN

Recent Clinical Trials for KETOPROFEN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Rennes University Hospital	PHASE4
M.D. Anderson Cancer Center	PHASE2
Siirt Training and Research Hospital	PHASE4

See all KETOPROFEN clinical trials

Pharmacology for KETOPROFEN

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for KETOPROFEN

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for KETOPROFEN

M01AE	Propionic acid derivatives
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

M02AA	Antiinflammatory preparations, non-steroids for topical use
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

US Patents and Regulatory Information for KETOPROFEN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	ORUVAIL	ketoprofen	CAPSULE, EXTENDED RELEASE;ORAL	019816-001	Sep 24, 1993		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Pharms Inc	ORUVAIL	ketoprofen	CAPSULE, EXTENDED RELEASE;ORAL	019816-003	Feb 8, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva	KETOPROFEN	ketoprofen	CAPSULE;ORAL	073515-001	Dec 22, 1992		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for KETOPROFEN

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-001	Jul 31, 1987	⤷ Start Trial	⤷ Start Trial
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-003	Jan 9, 1986	⤷ Start Trial	⤷ Start Trial
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-002	Jan 9, 1986	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.